Fiera Capital Corp Karuna Therapeutics, Inc. Transaction History

Fiera Capital Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 22, 2024	BUY	$161.01 - $317.85 $32,040 - $63,252	199 Added 0.08%	237,656 $75.2 Million
Q4 2023 Feb 08, 2024	BUY	$161.01 - $317.85 $32,040 - $63,252	199 Added 0.08%	237,656 $75.2 Million
Q3 2023 Aug 22, 2024	BUY	$164.66 - $218.08 $39.1 Million - $51.8 Million	237,457 New	237,457 $40.2 Million
Q3 2023 Nov 09, 2023	BUY	$164.66 - $218.08 $773,408 - $1.02 Million	4,697 Added 2.02%	237,457 $40.2 Million
Q2 2023 Aug 09, 2023	SELL	$176.32 - $240.22 $955,301 - $1.3 Million	-5,418 Reduced 2.27%	232,760 $50.5 Million
Q1 2023 Apr 26, 2023	BUY	$161.33 - $204.36 $12.2 Million - $15.4 Million	75,452 Added 46.37%	238,178 $43.3 Million
Q4 2022 Feb 08, 2023	BUY	$191.53 - $236.82 $11.7 Million - $14.5 Million	61,086 Added 60.1%	162,726 $32 Million
Q3 2022 Nov 03, 2022	BUY	$123.79 - $277.42 $12.6 Million - $28.2 Million	101,640 New	101,640 $20.7 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.